DOI: 10.1016/j.neuropharm.2006.11.009. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets

Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets

10.1016/j.neuropharm.2006.11.009

Crossref journal-article

Elsevier BV

Neuropharmacology (78)

Bibliography

Zhang, D., Saraf, A., Kolasa, T., Bhatia, P., Zheng, G. Z., Patel, M., Lannoye, G. S., Richardson, P., Stewart, A., Rogers, J. C., Brioni, J. D., & Surowy, C. S. (2007). Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology, 52(4), 1095â1105.

Authors 12

Di Zhang (first)
Anita Saraf (additional)
Teodozyi Kolasa (additional)
Pramila Bhatia (additional)
Guo Zhu Zheng (additional)
Meena Patel (additional)
Greg S. Lannoye (additional)
Paul Richardson (additional)
Andrew Stewart (additional)
John C. Rogers (additional)
Jorge D. Brioni (additional)
Carol S. Surowy (additional)

References 47 Referenced 86

Abouabdellah, A., Bas, M., Dargazanli, G., Hoornaert, C., Li, A.T., Medaisko, F., 2005. Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics. Patent US20050182130 A1.
Abouabdellah, A., Burnier, P., Hoornaert, C., Jeunesse, J., Puech, F., 2006. Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of some in therapeutics. Patent US20060089344 A1.
10.1016/j.chembiol.2005.08.011 / Chem. Biol. / Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes by Alexander (2005)
10.1021/ja062999h / J. Am. Chem. Soc. / The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases by Alexander (2006)
10.1161/01.CIR.0000143230.23252.D2 / Circulation / Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension by Batkai (2004)
10.1126/science.277.5329.1094 / Science / Functional role of high-affinity anandamide transport, as revealed by selective inhibition by Beltramo (1997)
Boger, D.L., 2004. Inhibitors of fatty acid amide hydrolase. Patent WO2004033652 A2.
10.1021/jm049614v / J. Med. Chem. / Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics by Boger (2005)
10.1073/pnas.97.10.5044 / Proc. Natl. Acad. Sci. U.S.A. / Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide by Boger (2000)
10.1126/science.1076535 / Science / Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling by Bracey (2002)
10.1016/S0014-2999(97)01297-1 / Eur. J. Pharmacol. / Potentiation of anandamide hypotension by the transport inhibitor, AM404 by Calignano (1997)
10.1038/sj.bjp.0706699 / Br. J. Pharmacol. / Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms by Chang (2006)
10.1016/j.phrs.2006.06.008 / Pharmacol. Res. / The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues by Clapper (2006)
10.1073/pnas.161191698 / Proc. Natl. Acad. Sci. U.S.A. / Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase by Cravatt (2001)
10.1016/S1367-5931(03)00079-6 / Curr. Opin. Chem. Biol. / Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system by Cravatt (2003)
10.1054/plef.2001.0349 / Prostaglandins Leukot. Essent. Fatty Acids / Anandamide receptors by Di Marzo (2002)
10.1007/s00018-004-3426-3 / Cell. Mol. Life Sci. / Triacylglycerol hydrolase: role in intracellular lipid metabolism by Dolinsky (2004)
10.1016/j.bcp.2005.01.017 / Biochem. Pharmacol. / Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma by Furihata (2005)
10.1073/pnas.0730816100 / Proc. Natl. Acad. Sci. U.S.A. / Evidence against the presence of an anandamide transporter by Glaser (2003)
10.1073/pnas.0509591102 / Proc. Natl. Acad. Sci. U.S.A. / Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis by Gobbi (2005)
10.1038/sj.bjp.0706348 / Br. J. Pharmacol. / Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors by Holt (2005)
10.1038/nmeth778 / Nat. Methods / A streamlined platform for high-content functional proteomics of primary human specimens by Jessani (2005)
10.1038/nm803 / Nat. Med. / Modulation of anxiety through blockade of anandamide hydrolysis by Kathuria (2003)
10.1021/bi002579j / Biochemistry / Profiling serine hydrolase activities in complex proteomes by Kidd (2001)
10.1016/j.bmcl.2004.12.085 / Bioorg. Med. Chem. Lett. / Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity by Leung (2005)
10.1038/nbt826 / Nat. Biotechnol. / Discovering potent and selective reversible inhibitors of enzymes in complex proteomes by Leung (2003)
10.1124/jpet.104.069401 / J. Pharmacol. Exp. Ther. / Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity by Lichtman (2004)
10.1002/jps.20542 / J. Pharm. Sci. / Enzymes involved in the bioconversion of ester-based prodrugs by Liederer (2006)
10.1074/jbc.M413585200 / J. Biol. Chem. / Isolation and characterization of a microsomal acid retinyl ester hydrolase by Linke (2005)
10.1073/pnas.96.26.14694 / Proc. Natl. Acad. Sci. U.S.A. / Activity-based protein profiling: the serine hydrolases by Liu (1999)
10.1039/b503887a / Chem. Commun. (Camb.) / QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation by Lodola (2005)
10.1172/JCI200419465 / J. Clin. Invest. / The endogenous cannabinoid system protects against colonic inflammation by Massa (2004)
10.1146/annurev.biochem.74.082803.133450 / Annu. Rev. Biochem. / Structure and function of fatty acid amide hydrolase by McKinney (2005)
10.1073/pnas.0507470102 / Proc. Natl. Acad. Sci. U.S.A. / Identification of a high-affinity binding site involved in the transport of endocannabinoids by Moore (2005)
10.1021/jm031140x / J. Med. Chem. / Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure–activity relationships, and molecular modeling studies by Mor (2004)
10.1152/ajpheart.00107.2005 / Am. J. Physiol. Heart Circ. Physiol. / Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase by Pacher (2005)
10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4 / Proteomics / Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes by Patricelli (2001)
{'key': '10.1016/j.neuropharm.2006.11.009_bib38', 'first-page': '1', 'article-title': 'Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo', 'author': 'Perra', 'year': '2005', 'journal-title': 'Psychopharmacology (Berl.)'} / Psychopharmacology (Berl.) / Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo by Perra (2005)
{'key': '10.1016/j.neuropharm.2006.11.009_bib39', 'article-title': 'LY2077855: a novel, potent, selective, non-endocannabinoid related inhibitor of anandamide inactivation demonstrates robust analgesic effects in an in vivo pain model', 'author': 'Porter', 'year': '2004', 'journal-title': 'Soc. Neurosci.'} / Soc. Neurosci. / LY2077855: a novel, potent, selective, non-endocannabinoid related inhibitor of anandamide inactivation demonstrates robust analgesic effects in an in vivo pain model by Porter (2004)
10.1124/jpet.104.081265 / J. Pharmacol. Exp. Ther. / Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide by Quinney (2005)
10.1046/j.1432-1033.2002.03121.x / Eur. J. Biochem. / Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate by Sanghani (2002)
10.1146/annurev.pharmtox.38.1.257 / Annu. Rev. Pharmacol. Toxicol. / The mammalian carboxylesterases: from molecules to functions by Satoh (1998)
Sit, S.Y., Xie, K., 2002. Bisarylimidazolyl fatty acid amide hydrolase inhibitors. Patent US 6562846 B2.
10.1021/jm049011j / J. Med. Chem. / Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases by Wadkins (2005)
10.1124/mol.65.6.1336 / Mol. Pharmacol. / Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure–activity relationship analysis, and biological activity by Wadkins (2004)
10.1021/tx015508+ / Chem. Res. Toxicol. / Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility by Wheelock (2001)
10.1074/jbc.M511288200 / J. Biol. Chem. / Association of catsper1 or -2 with Cav3.3 leads to suppression of T-type calcium channel activity by Zhang (2006)

Dates

Type	When
Created	18 years, 7 months ago (Jan. 10, 2007, 9:28 a.m.)
Deposited	6 years, 7 months ago (Jan. 9, 2019, 11:22 p.m.)
Indexed	1 year, 1 month ago (July 15, 2024, 1:50 p.m.)
Issued	18 years, 6 months ago (March 1, 2007)
Published	18 years, 6 months ago (March 1, 2007)
Published Print	18 years, 6 months ago (March 1, 2007)

Funders 0

None

BibTeX

@article{Zhang_2007, title={Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets}, volume={52}, ISSN={0028-3908}, url={http://dx.doi.org/10.1016/j.neuropharm.2006.11.009}, DOI={10.1016/j.neuropharm.2006.11.009}, number={4}, journal={Neuropharmacology}, publisher={Elsevier BV}, author={Zhang, Di and Saraf, Anita and Kolasa, Teodozyi and Bhatia, Pramila and Zheng, Guo Zhu and Patel, Meena and Lannoye, Greg S. and Richardson, Paul and Stewart, Andrew and Rogers, John C. and Brioni, Jorge D. and Surowy, Carol S.}, year={2007}, month=mar, pages={1095–1105} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        7,
        15
      ]
    ],
    "date-time": "2024-07-15T17:50:04Z",
    "timestamp": 1721065804937
  },
  "reference-count": 47,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2007,
            3,
            1
          ]
        ],
        "date-time": "2007-03-01T00:00:00Z",
        "timestamp": 1172707200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        3
      ]
    ]
  },
  "DOI": "10.1016/j.neuropharm.2006.11.009",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2007,
        1,
        10
      ]
    ],
    "date-time": "2007-01-10T14:28:20Z",
    "timestamp": 1168439300000
  },
  "page": "1095-1105",
  "source": "Crossref",
  "is-referenced-by-count": 86,
  "title": "Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets",
  "prefix": "10.1016",
  "volume": "52",
  "author": [
    {
      "given": "Di",
      "family": "Zhang",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Anita",
      "family": "Saraf",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Teodozyi",
      "family": "Kolasa",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Pramila",
      "family": "Bhatia",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Guo Zhu",
      "family": "Zheng",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Meena",
      "family": "Patel",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Greg S.",
      "family": "Lannoye",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Paul",
      "family": "Richardson",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Andrew",
      "family": "Stewart",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "John C.",
      "family": "Rogers",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jorge D.",
      "family": "Brioni",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Carol S.",
      "family": "Surowy",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib1",
      "unstructured": "Abouabdellah, A., Bas, M., Dargazanli, G., Hoornaert, C., Li, A.T., Medaisko, F., 2005. Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics. Patent US20050182130 A1."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib2",
      "unstructured": "Abouabdellah, A., Burnier, P., Hoornaert, C., Jeunesse, J., Puech, F., 2006. Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of some in therapeutics. Patent US20060089344 A1."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "1179",
      "DOI": "10.1016/j.chembiol.2005.08.011",
      "article-title": "Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes",
      "volume": "12",
      "author": "Alexander",
      "year": "2005",
      "journal-title": "Chem. Biol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "9699",
      "DOI": "10.1021/ja062999h",
      "article-title": "The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases",
      "volume": "128",
      "author": "Alexander",
      "year": "2006",
      "journal-title": "J. Am. Chem. Soc."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "1996",
      "DOI": "10.1161/01.CIR.0000143230.23252.D2",
      "article-title": "Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension",
      "volume": "110",
      "author": "Batkai",
      "year": "2004",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "1094",
      "DOI": "10.1126/science.277.5329.1094",
      "article-title": "Functional role of high-affinity anandamide transport, as revealed by selective inhibition",
      "volume": "277",
      "author": "Beltramo",
      "year": "1997",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib7",
      "unstructured": "Boger, D.L., 2004. Inhibitors of fatty acid amide hydrolase. Patent WO2004033652 A2."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "1849",
      "DOI": "10.1021/jm049614v",
      "article-title": "Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty\u00a0acid amide hydrolase effective as analgesics",
      "volume": "48",
      "author": "Boger",
      "year": "2005",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "5044",
      "DOI": "10.1073/pnas.97.10.5044",
      "article-title": "Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide",
      "volume": "97",
      "author": "Boger",
      "year": "2000",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "1793",
      "DOI": "10.1126/science.1076535",
      "article-title": "Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling",
      "volume": "298",
      "author": "Bracey",
      "year": "2002",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "R1",
      "DOI": "10.1016/S0014-2999(97)01297-1",
      "article-title": "Potentiation of anandamide hypotension by the transport inhibitor, AM404",
      "volume": "337",
      "author": "Calignano",
      "year": "1997",
      "journal-title": "Eur. J. Pharmacol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "102",
      "DOI": "10.1038/sj.bjp.0706699",
      "article-title": "Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms",
      "volume": "148",
      "author": "Chang",
      "year": "2006",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "DOI": "10.1016/j.phrs.2006.06.008",
      "article-title": "The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues",
      "volume": "54",
      "author": "Clapper",
      "year": "2006",
      "journal-title": "Pharmacol. Res."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "9371",
      "DOI": "10.1073/pnas.161191698",
      "article-title": "Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase",
      "volume": "98",
      "author": "Cravatt",
      "year": "2001",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "469",
      "DOI": "10.1016/S1367-5931(03)00079-6",
      "article-title": "Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system",
      "volume": "7",
      "author": "Cravatt",
      "year": "2003",
      "journal-title": "Curr. Opin. Chem. Biol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "DOI": "10.1054/plef.2001.0349",
      "article-title": "Anandamide receptors",
      "volume": "66",
      "author": "Di Marzo",
      "year": "2002",
      "journal-title": "Prostaglandins Leukot. Essent. Fatty Acids"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "DOI": "10.1007/s00018-004-3426-3",
      "article-title": "Triacylglycerol hydrolase: role in intracellular lipid metabolism",
      "volume": "61",
      "author": "Dolinsky",
      "year": "2004",
      "journal-title": "Cell. Mol. Life Sci."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1287",
      "DOI": "10.1016/j.bcp.2005.01.017",
      "article-title": "Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma",
      "volume": "69",
      "author": "Furihata",
      "year": "2005",
      "journal-title": "Biochem. Pharmacol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "4269",
      "DOI": "10.1073/pnas.0730816100",
      "article-title": "Evidence against the presence of an anandamide transporter",
      "volume": "100",
      "author": "Glaser",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "18620",
      "DOI": "10.1073/pnas.0509591102",
      "article-title": "Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis",
      "volume": "102",
      "author": "Gobbi",
      "year": "2005",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "467",
      "DOI": "10.1038/sj.bjp.0706348",
      "article-title": "Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors",
      "volume": "146",
      "author": "Holt",
      "year": "2005",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "691",
      "DOI": "10.1038/nmeth778",
      "article-title": "A streamlined platform for high-content functional proteomics of primary human specimens",
      "volume": "2",
      "author": "Jessani",
      "year": "2005",
      "journal-title": "Nat. Methods"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "DOI": "10.1038/nm803",
      "article-title": "Modulation of anxiety through blockade of anandamide hydrolysis",
      "volume": "9",
      "author": "Kathuria",
      "year": "2003",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "4005",
      "DOI": "10.1021/bi002579j",
      "article-title": "Profiling serine hydrolase activities in complex proteomes",
      "volume": "40",
      "author": "Kidd",
      "year": "2001",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "1423",
      "DOI": "10.1016/j.bmcl.2004.12.085",
      "article-title": "Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity",
      "volume": "15",
      "author": "Leung",
      "year": "2005",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "687",
      "DOI": "10.1038/nbt826",
      "article-title": "Discovering potent and selective reversible inhibitors of enzymes in complex proteomes",
      "volume": "21",
      "author": "Leung",
      "year": "2003",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "DOI": "10.1124/jpet.104.069401",
      "article-title": "Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity",
      "volume": "311",
      "author": "Lichtman",
      "year": "2004",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "1177",
      "DOI": "10.1002/jps.20542",
      "article-title": "Enzymes involved in the bioconversion of ester-based prodrugs",
      "volume": "95",
      "author": "Liederer",
      "year": "2006",
      "journal-title": "J. Pharm. Sci."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "23287",
      "DOI": "10.1074/jbc.M413585200",
      "article-title": "Isolation and characterization of a microsomal acid retinyl ester hydrolase",
      "volume": "280",
      "author": "Linke",
      "year": "2005",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "14694",
      "DOI": "10.1073/pnas.96.26.14694",
      "article-title": "Activity-based protein profiling: the serine hydrolases",
      "volume": "96",
      "author": "Liu",
      "year": "1999",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "4399",
      "DOI": "10.1039/b503887a",
      "article-title": "QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation",
      "author": "Lodola",
      "year": "2005",
      "journal-title": "Chem. Commun. (Camb.)"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1202",
      "DOI": "10.1172/JCI200419465",
      "article-title": "The endogenous cannabinoid system protects against colonic inflammation",
      "volume": "113",
      "author": "Massa",
      "year": "2004",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "411",
      "DOI": "10.1146/annurev.biochem.74.082803.133450",
      "article-title": "Structure and function of fatty acid amide hydrolase",
      "volume": "74",
      "author": "McKinney",
      "year": "2005",
      "journal-title": "Annu. Rev. Biochem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "17852",
      "DOI": "10.1073/pnas.0507470102",
      "article-title": "Identification of a high-affinity binding site involved in the transport of endocannabinoids",
      "volume": "102",
      "author": "Moore",
      "year": "2005",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "4998",
      "DOI": "10.1021/jm031140x",
      "article-title": "Cyclohexylcarbamic acid 3\u2032- or 4\u2032-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure\u2013activity relationships, and molecular modeling studies",
      "volume": "47",
      "author": "Mor",
      "year": "2004",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "H533",
      "DOI": "10.1152/ajpheart.00107.2005",
      "article-title": "Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase",
      "volume": "289",
      "author": "Pacher",
      "year": "2005",
      "journal-title": "Am. J. Physiol. Heart Circ. Physiol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "1067",
      "DOI": "10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4",
      "article-title": "Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes",
      "volume": "1",
      "author": "Patricelli",
      "year": "2001",
      "journal-title": "Proteomics"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib38",
      "first-page": "1",
      "article-title": "Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo",
      "author": "Perra",
      "year": "2005",
      "journal-title": "Psychopharmacology (Berl.)"
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib39",
      "article-title": "LY2077855: a novel, potent, selective, non-endocannabinoid related inhibitor of anandamide inactivation demonstrates robust analgesic effects in an in vivo pain model",
      "author": "Porter",
      "year": "2004",
      "journal-title": "Soc. Neurosci."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "1011",
      "DOI": "10.1124/jpet.104.081265",
      "article-title": "Hydrolysis of capecitabine to 5\u2032-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide",
      "volume": "313",
      "author": "Quinney",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "4387",
      "DOI": "10.1046/j.1432-1033.2002.03121.x",
      "article-title": "Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate",
      "volume": "269",
      "author": "Sanghani",
      "year": "2002",
      "journal-title": "Eur. J. Biochem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "DOI": "10.1146/annurev.pharmtox.38.1.257",
      "article-title": "The mammalian carboxylesterases: from molecules to functions",
      "volume": "38",
      "author": "Satoh",
      "year": "1998",
      "journal-title": "Annu. Rev. Pharmacol. Toxicol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib43",
      "unstructured": "Sit, S.Y., Xie, K., 2002. Bisarylimidazolyl fatty acid amide hydrolase inhibitors. Patent US 6562846 B2."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "2906",
      "DOI": "10.1021/jm049011j",
      "article-title": "Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases",
      "volume": "48",
      "author": "Wadkins",
      "year": "2005",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "1336",
      "DOI": "10.1124/mol.65.6.1336",
      "article-title": "Discovery of novel selective inhibitors of human intestinal carboxylesterase for the\u00a0amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure\u2013activity relationship analysis, and biological activity",
      "volume": "65",
      "author": "Wadkins",
      "year": "2004",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "1563",
      "DOI": "10.1021/tx015508+",
      "article-title": "Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility",
      "volume": "14",
      "author": "Wheelock",
      "year": "2001",
      "journal-title": "Chem. Res. Toxicol."
    },
    {
      "key": "10.1016/j.neuropharm.2006.11.009_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "22332",
      "DOI": "10.1074/jbc.M511288200",
      "article-title": "Association of catsper1 or -2 with Cav3.3 leads to suppression of T-type calcium channel activity",
      "volume": "281",
      "author": "Zhang",
      "year": "2006",
      "journal-title": "J.\u00a0Biol. Chem."
    }
  ],
  "container-title": "Neuropharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0028390806003959?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0028390806003959?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        1,
        10
      ]
    ],
    "date-time": "2019-01-10T04:22:05Z",
    "timestamp": 1547094125000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0028390806003959"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2007,
        3
      ]
    ]
  },
  "references-count": 47,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2007,
          3
        ]
      ]
    }
  },
  "alternative-id": [
    "S0028390806003959"
  ],
  "URL": "http://dx.doi.org/10.1016/j.neuropharm.2006.11.009",
  "relation": {},
  "ISSN": [
    "0028-3908"
  ],
  "subject": [],
  "container-title-short": "Neuropharmacology",
  "published": {
    "date-parts": [
      [
        2007,
        3
      ]
    ]
  }
}